Prevail Innovative Wealth Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29,923
Closed -$4.38M 231
2025
Q3
$4.38M Buy
+29,923
New +$4.52M 0.85% 36
2024
Q3
Sell
-26,592
Closed -$4.61M 207
2024
Q2
$4.61M Buy
26,592
+7,615
+40% +$1.27M 1.63% 9
2024
Q1
$3.21M Buy
18,977
+3,738
+25% +$700K 1.19% 19
2023
Q4
$3.01M Buy
15,239
+1,861
+14% +$329K 1.44% 16
2023
Q3
$2.33M Buy
13,378
+4,901
+58% +$890K 1.21% 32
2023
Q2
$1.46M Buy
+8,477
New +$1.47M 0.8% 43

Other funds holding ZTS

Prevail Innovative Wealth Advisors's ZTS Position: Q4 2025 in Review

Prevail Innovative Wealth Advisors sold out of Zoetis (ZTS) in Q4 2025, closing a stake of 29,923 shares — an estimated $4.38M sold.

Prevail Innovative Wealth Advisors first reported a position in ZTS in Q2 2023 and held it in 6 quarters. The position peaked at $4.61M in Q2 2024. 1,680 funds tracked by Wall St. Rank hold ZTS as of Q4 2025.

  • Prevail Innovative Wealth Advisors reported no remaining Zoetis position as of Q4 2025 after selling out during the quarter.
  • Prevail Innovative Wealth Advisors sold 29,923 Zoetis shares in Q4 2025, an estimated $4.38M.
  • Prevail Innovative Wealth Advisors first reported a position in Zoetis in Q2 2023 and held it in 6 quarters.
  • Prevail Innovative Wealth Advisors's Zoetis position peaked at $4.61M in Q2 2024.
  • 1,680 funds tracked by Wall St. Rank held Zoetis as of Q4 2025.

Based on Prevail Innovative Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.